Skip to main content
SpringerLink
Log in

Patterns of NICE drug TAs in 2013

  • Review
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. incremental cost-effectiveness ratio

  2. incremental cost-effectiveness ratio

Reference

  • McGee MA, et al. Draft Versus Final Guidance in Nice's Drug Technology Appraisal Process. 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PHP183, 2 Nov 2013.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patterns of NICE drug TAs in 2013. PharmacoEcon Outcomes News 692, 8 (2013). https://doi.org/10.1007/s40274-013-0891-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0891-7

Search

Navigation